Research Database

64 studies found

Positive

60.9%

Negative

23.4%

Inconclusive

15.6%

Page 2 of 4

PositiveReview/Other

Protection of CCl 4-induced hepatic and renal damage by linalool

2022

Chronic Kidney DiseaseHepatitisLiver Failure

PositiveReview/Other

CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway

2021

Alcoholic Liver Disease

PositiveAnimal Study -

Therapeutic potential of beta-caryophyllene against aflatoxin B1-Induced liver toxicity: biochemical and molecular insights in rats

2021

Cancer

PositiveClinical Trial

Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial

2021

Fatty Liver Disease

PositiveReview/Other

Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models

2021

Diabetes

NegativeAnimal Study - Veterinary Clinical Trial

Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol

2021

Epilepsy - Dravet Syndrome

PositiveAnimal Study -

Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice

2021

Hepatitis

InconclusiveReview/Other

Lack of Association Between Recent Cannabis Use and Advanced Liver Fibrosis Among HIV-positive Heavy Drinkers

2021

Addiction

PositiveAnimal Study -

Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol

2021

Liver Failure

NegativeAnimal Study - Veterinary Clinical Trial

Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions

2021

Cannabis Adverse Effects

PositiveReview/Other

The Impact of Marijuana Use on Liver Transplant Recipients: A 900 Patient Single Center Experience

2021

Liver Failure

NegativeReview/Other

Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

2021

Cardiovascular Diseases (CVD)

PositiveReview/Other

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

2021

Fatty Liver Disease

PositiveReview/Other

Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

2020

Atherosclerosis

PositiveReview/Other

Cannabinoids and Chronic Liver Diseases

2020

Alcoholic Liver Disease

PositiveReview/Other

Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes

2020

Fatty Liver Disease

PositiveAnimal Study -

The effect of α-terpineol enantiomers on biomarkers of rats fed a high-fat diet

2020

Diabetes

NegativeReview/Other

Genotoxic Effects Induced by Beta-Myrcene Following Metabolism by Liver HepG2/C3A Human Cells

2019

Fatty Liver Disease

InconclusiveReview/Other

Use of Cannabis in Gastroenterological and Hepatic Disorders

2019

Alcoholic Liver Disease

PositiveClinical Trial

Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial

2019

Cognitive Dysfunction

Command Palette

Research Database

Protection of CCl 4-induced hepatic and renal damage by linalool

CBD Alleviates Liver Injuries in Alcoholics With High-Fat High-Cholesterol Diet Through Regulating NLRP3 Inflammasome–Pyroptosis Pathway

Therapeutic potential of beta-caryophyllene against aflatoxin B1-Induced liver toxicity: biochemical and molecular insights in rats

Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial

Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models

Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol

Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4-/- Mice

Lack of Association Between Recent Cannabis Use and Advanced Liver Fibrosis Among HIV-positive Heavy Drinkers

Changes in Hepatic Phospholipid Metabolism in Rats under UV Irradiation and Topically Treated with Cannabidiol

Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions

The Impact of Marijuana Use on Liver Transplant Recipients: A 900 Patient Single Center Experience

Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

Evaluation of the cardioprotective effects of crystalloid del Nido cardioplegia solution via a rapid and accurate cardiac marker: heart-type fatty acid-binding protein

Cannabinoids and Chronic Liver Diseases

Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes

The effect of α-terpineol enantiomers on biomarkers of rats fed a high-fat diet

Genotoxic Effects Induced by Beta-Myrcene Following Metabolism by Liver HepG2/C3A Human Cells

Use of Cannabis in Gastroenterological and Hepatic Disorders

Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial